OFIX icon

Orthofix Medical

130 hedge funds and large institutions have $467M invested in Orthofix Medical in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 51 increasing their positions, 48 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital inflows, than outflows

Capital inflows: $45.8M | Capital outflows: $33.1M

1.71% more ownership

Funds ownership: 97.82% → 99.53% (+1.7%)

6% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 48

13% less funds holding

Funds holding: 149 → 130 (-19)

56% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 27

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
130
Holders Change
-19
Holders Change %
-12.75%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
51
Reduced
48
Closed
27
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

OFIX Hedge Fund Activity: Q2 2022 in Review

130 of the 5,962 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q2 2022, worth a combined $467M — down 26% from $635M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of OFIX and 12 opened new positions — a net loss of 15 holders — while 48 trimmed existing stakes and 51 added.

The largest buyer was Polar Asset Management Partners, adding an estimated $7.84M. The largest seller was Endurant Capital Management, exiting entirely with an estimated $14.2M sold.

  • 130 institutional investors held Orthofix Medical (OFIX) as of Q2 2022, down from 149 in Q1 2022.
  • Funds reported $467M of Orthofix Medical stock for Q2 2022, down 26% quarter-over-quarter.
  • 12 funds opened new Orthofix Medical positions in Q2 2022 and 27 closed out, a net change of -15 holders.
  • The largest Orthofix Medical buyer in Q2 2022 was Polar Asset Management Partners, an estimated $7.84M added.
  • The largest Orthofix Medical seller in Q2 2022 was Endurant Capital Management, an estimated $14.2M sold.

Based on aggregated 13F filings for Q2 2022.